You are here

Interview with Kazuo Tamura at MASCC 2016: Delayed nausea and vomiting - what are the current treatment challenges?

MASCC Interview 3 Kazuo Tamura

Kazuo Tamura is Professor in the General Medical Resource Center at Fukuoka University, Japan. In this interview he discusses the challenges involved in managing chemotherapy-induced nausea and vomiting. One challenge lies in monitoring patients who have chemotherapy in the clinic and then return home, only to incur delayed nausea or vomiting. If the patient does not seek help from the clinic, then several concerning health issues can occur, hence close monitoring is important. Current antiemetic guidelines help to effectively control vomiting, but are not so effective against delayed nausea, hence more potent agents are required to combat nausea. Prof Tamura reviews an upcoming trial using combination drug therapy for controlling nausea and vomiting. Dr Tamura reviews the impact of nausea on the quality of life of cancer patients, novel uses of existing drugs, and discusses the importance of a multi-disciplinary team, including pharmacists, nurses and other medical professionals as pivotal in managing these symptoms and in increasing health-related quality of life. 

This interview was recorded at the June 2016 annual meeting of MASCC in Adelaide Australia. It was conducted by medical writer Rhonda Oshanek.

Search this site

Stay up-to-date with our monthly e-alert

If you want to regularly receive information on what is happening in Quality of Life in Oncology research sign up to our e-alert.

Subscribe »

QOL (Quality of Life) newsletter e-alert

NEW! Free access to the digital version of a new publication in Cancer Supportive Care

Cancer cachexia: mechanisms and progress in treatment

Authors: Egidio Del Fabbro, Kenneth Fearon, Florian Strasser

This book was supported by an educational grant from Helsinn Healthcare SA.

Featured videos

Quality of Life promotional video

Made possible by an educational grant from Helsinn

Helsinn does not have any influence on the content and all items are subject to independent peer and editorial review

Society Partners

European Cancer Organisation Logo